EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): An open-label randomized controlled phase II study.

作者: Elizabeth Catherine Smyth , Maren Kristina Knoedler , Magnus Nilsson , Anna Dorothea Wagner , Markus H. Moehler

DOI: 10.1200/JCO.2020.38.4_SUPPL.TPS467

关键词: CancerIn patientLymphPreoperative chemotherapyRadiologyPhases of clinical researchImmunotherapyAdjuvantMedicineChemotherapy

摘要: TPS467Background: Gastroesophageal adenocarcinoma patients with metastatic lymph nodes (ypN+) or a microscopically incomplete surgical resection (R1) following neoadjuvant chemotherapy are at high ...

参考文章(0)